Two series of 4-arylpiperazine- and 4-benzylpiperidine naphthyl ethers were designed based on structure-activity relationship (SAR) and docking model of reported monoamine neurotransmitters reuptake inhibitors. The compounds were synthesized in 3-simple steps and their biological activities were evaluated. Several compounds were proven to be potent inhibitors of serotonin and norepinephrine reuptake. Computer docking was performed to study the interaction of the most potent compound 35 with human serotonin transporter. The results of the analyses suggest that 4-arylpiperazine- and 4-benzylpiperidine naphthyl ethers might be promising antidepressants worthy of further studies.
Keywords: 4-Arylpiperazine; 4-Benzylpiperidine; Depression; Docking; Naphthyl ether; Norepinephrine reuptake inhibitor; Serotonin reuptake inhibitor.
Copyright © 2018 Elsevier Ltd. All rights reserved.